"Visit Upstate Cardiology Greenville in Greenville, South Carolina. Upstate Cardiology Greenville is one of the many Cardiology & Heart Institutes locations at Bon Secours providing good help to those in need."

During the past decade, Upstate Cardiology conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Upstate Cardiology" #1 sponsor was "Biotronik, Inc." with 4 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Upstate Cardiology" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Upstate Cardiology" are "Atrial Fibrillation" (2 trials), "Heart Failure" (2 trials), "Implantable Defibrillator User" (2 trials), "Myocardial Infarction" (2 trials) and "ASCVD" (1 trials). Many other conditions were trialed in "Upstate Cardiology" in a lesser frequency.

Most popular intervention types in "Upstate Cardiology" are "Device" (4 trials), "Drug" (4 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Acetylsalicylic acid" (1 trials), "Acetylsalicylic acid placebo" (1 trials), "Apixaban" (1 trials) and "CRT-DX" (1 trials). Other intervention names were less common.

The vast majority of trials in "Upstate Cardiology" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Upstate Cardiology". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Upstate Cardiology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Upstate Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".